| A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems M Kazlauskiene, G Kostiuk, Č Venclovas, G Tamulaitis, V Siksnys Science 357 (6351), 605-609, 2017 | 475 | 2017 |
| Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus G Tamulaitis, M Kazlauskiene, E Manakova, Č Venclovas, AO Nwokeoji, ... Molecular cell 56 (4), 506-517, 2014 | 345 | 2014 |
| Spatiotemporal control of type III-A CRISPR-Cas immunity: coupling DNA degradation with the target RNA recognition M Kazlauskiene, G Tamulaitis, G Kostiuk, Č Venclovas, V Siksnys Molecular cell 62 (2), 295-306, 2016 | 289 | 2016 |
| Binding affinity in drug design: experimental and computational techniques V Kairys, L Baranauskiene, M Kazlauskiene, D Matulis, E Kazlauskas Expert opinion on drug discovery 14 (8), 755-768, 2019 | 156 | 2019 |
| Hakai is required for stabilization of core components of the m6A mRNA methylation machinery P Bawankar, T Lence, C Paolantoni, IU Haussmann, M Kazlauskiene, ... Nature communications 12 (1), 3778, 2021 | 130 | 2021 |
| Type III-A CRISPR-associated protein Csm6 degrades cyclic hexa-adenylate activator using both CARF and HEPN domains D Smalakyte, M Kazlauskiene, J F. Havelund, A Rukšėnaitė, A Rimaite, ... Nucleic Acids Research 48 (16), 9204-9217, 2020 | 44 | 2020 |
| Genetic dissection of the type III-A CRISPR-Cas system csm complex reveals roles of individual subunits I Mogila, M Kazlauskiene, S Valinskyte, G Tamulaitiene, G Tamulaitis, ... Cell reports 26 (10), 2753-2765. e4, 2019 | 34 | 2019 |
| Targeted RNA knockdown and knockout by type III-A Csm complexes T Fricke, M Bochtler, G Tamulaitis, M Kazlauskiene US Patent 11,274,317, 2022 | 5 | 2022 |
| Recent advances in computational and experimental protein-ligand affinity determination techniques V Kairys, L Baranauskiene, M Kazlauskiene, A Zubrienė, V Petrauskas, ... Expert Opinion on Drug Discovery 19 (6), 649-670, 2024 | 3 | 2024 |
| Production of cyclic adenylates and their use as allosteric regulators V Siksnys, M Kazlauskiene, G Kostiuk, G Tamulaitis US Patent App. 16/618,238, 2021 | 2 | 2021 |
| Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus V Siksnys, M Kazlauskiene, G Tamulaitis US Patent 10,385,336, 2019 | 2 | 2019 |
| Regulation of CRISPR-associated rossman fold (CARF) domain containing proteins by oligoadenylates V Šikšnys, M Kazlauskiene, G Kostiuk, G Tamulaitis US Patent 12,123,031, 2024 | | 2024 |
| Characterization of Streptococcus thermophilus Csm complex mediated CRISPR interference in vitro G Tamulaitis, M Kazlauskiene, E Manakova, C Venclovas, AO Nwokeoji, ... FEBS JOURNAL 281, 678-678, 2014 | | 2014 |
